Candiac, Canada

Clint A James

This inventor holds 26 USPTO granted patents and 2 published patent applications and 19 EPO patents, primarily in Antiviral Compounds. Top assignees: Bristol-Myers Squibb Compnay, Boehringer Ingelheim International Gmbh, Viiv Healthcare UK (No.5) Limited. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clint A James. Retrieved from https://idiyas.com/inventor/clint-a-james

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26 

% Patents Active = 76.9

 

Average Co-Inventor Count = 12.3

ph-index = 11

Forward Citations = 399(Granted Patents)


Location History:

  • Laprairie, CA (2011)
  • Longueuil, CA (2008 - 2012)
  • Candiac, CA (2012 - 2017)
  • Laval, CA (2013 - 2021)

Company Filing History:


Years Active: 2008-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Pyrrolotriazine Compounds
Hepatitis C Inhibitors
HIV Attachment Inhibitors
Tricyclic Alkene Derivatives
Piperidine Amide Derivatives
Cytomegalovirus Inhibitors
Piperazine Amidines
Indole Derivatives
Azaindole Compounds
Heterocyclic Amides
Antiviral Agents
HIV Replication Inhibitors
26 patents (USPTO):Explore Patents

Certainly! Here is an article about the inventor Clint A James based on the given data:

Title: Unveiling the Innovation Journey of Clint A James

Introduction:

In the realm of groundbreaking inventions and cutting-edge patents, Clint A James stands tall as a prolific inventor who has made significant contributions to the field. Hailing from Candiac, CA, Clint A James has a remarkable track record with 26 patents to his name, showcasing his ingenuity and commitment to innovation.

Latest Patents:

Clint A James's latest patents delve into revolutionary advancements in the medical field. One such patent involves Pyrrolotriazine compounds and methods of inhibiting TAM kinases, offering new avenues for cancer treatment. Another notable patent focuses on Hepatitis C virus inhibitors, providing promising solutions for combating HCV infection.

Career Highlights:

Throughout his illustrious career, Clint A James has lent his expertise to renowned companies such as Bristol-Myers Squibb Company and Boehringer Ingelheim International GmbH. His innovative spirit and dedication to scientific excellence have played a pivotal role in shaping the landscape of pharmaceutical research and development.

Collaborations:

In his pursuit of pioneering discoveries, Clint A James has collaborated with esteemed professionals in the field. Noteworthy coworkers include Edward H Ruediger and Nicholas A Meanwell, who have shared in the journey of innovation and shared success with Clint A James.

Conclusion:

In conclusion, Clint A James emerges as a visionary inventor whose accomplishments reverberate across the realms of science and technology. His relentless pursuit of excellence and unwavering passion for innovation underscore his status as a trailblazer in the world of patents and inventions. Clint A James's work continues to inspire future generations of inventors and researchers, leaving an indelible mark on the landscape of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…